Evidence map›Paper›PMID 41523797›Full record

ReviewTherapeutic advances in musculoskeletal disease2026

Imaging-guided stratification in giant cell arteritis: prognostic and therapeutic implications.

Juan Molina-Collada, Cristina Ponte, Valentin Sebastian Schäfer, Eugenio de Miguel

Abstract readReview
In one paragraph

Review in Therapeutic advances in musculoskeletal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan Molina-ColladaDepartment of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.ORCID https://orcid.org/0000-0001-5191-7802
Cristina PonteDepartment of Rheumatology, Unidade Local de Saúde de Santa Maria, Lisboa, Portugal.
Valentin Sebastian SchäferClinic of Internal Medicine III, Department of Oncology, Hematology Rheumatology and Clinical Immunology, University Hospital Bonn, Bonn, Germany.
Eugenio de MiguelDepartment of Rheumatology, Hospital Universitario La Paz, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imaging has become a cornerstone in the clinical management of giant cell arteritis (GCA), with its role extending beyond diagnosis to include disease monitoring, risk stratification of relapse, and therapeutic decision-making. While imaging modalities have been well-established for diagnostic purposes, growing evidence supports their utility in tracking disease activity and stratifying the risk of relapse. In this narrative review, we discuss the available evidence on the prognostic and therapeutic implications of imaging-guided stratification in GCA, and highlight areas that require further research. Ultrasound assessment of intima-media thickness shows measurable improvement following treatment. While this response is relatively rapid in the cranial arteries, it occurs slowly or very slowly in extracranial vessels. Moreover, ultrasound signs and quantitative indices may be useful for distinguishing remission from relapse. Similarly, arterial inflammation assessed by

Indexed as

giant cell arteritisimaginglarge vessel vasculitisMRIPET-CTrisk stratificationultrasound

Identifiers

PMID41523797
PMCPMC12779914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.